Introduction
Epilepsy is one of the most common serious brain disorders, affecting over 50 million people worldwide [1] . The prevalence of epilepsy has been estimated at approximately 0.5-1.0% of the general population [2] [3] [4] . In people with intellectual disabilities, estimates of the prevalence of epilepsy vary due to differences in the methods used and inherent population biases [5] . Despite this variation, it is clear that the prevalence of epilepsy in people with intellectual disabilities is much greater than in the general population [6] . Reported rates range, for example, from 16 .1% of 1595 people with intellectual disabilities identified in South Wales [7] to 30.7% in a random sample of 753 people with intellectual disabilities aged 40 or more from Ireland's National Intellectual Disability Database (NIDD) [8] . In a systematic review of the prevalence of chronic health conditions in children with intellectual disabilities, the most common condition was epilepsy [9] with prevalence rates in the 14 studies identified ranging from 5.5% to 35.0%, with an overall weighted mean prevalence rate of 22.0% (95% CI 20.8, 23.2).
Mortality is increased in people with epilepsy, with a recent systematic review and meta-analysis of 38 epilepsy cohorts including over 165,000 patients finding a pooled relative risk of death of 3.3 (95% CI 2.83, 3.92) compared to the general population [10] . Risk of premature death was lowest in idiopathic epilepsy and in people with epilepsy who had attained seizure freedom.
People with epilepsy may have elevated mortality from external causes such as accidents including drowning [11] . However, Sudden Unexpected Death in Epilepsy (SUDEP) is the most important category of epilepsy related death [12] . In the UK it is estimated that 500 deaths per annum are SUDEP [13] . Overall findings regarding the risk of SUDEP in people with intellectual disabilities are inconsistent. One systematic review of risk factors for SUDEP based on 27 studies found that 'mental retardation' was not a risk factor for SUDEP [14] . However, it is not clear how many studies in the review included intellectual disability as a risk factor. A more recent review identified 23 articles which considered intellectual disability and SUDEP of which 14 found intellectual disability to be a risk factor for SUDEP and none found intellectual disability to be a protective factor in SUDEP [15] .
For people with intellectual disabilities, epilepsy or convulsions has been identified as an important and to some extent potentially preventable cause of death [16] . The study looked at ages and causes of death recorded on death certificates for people with intellectual disabilities, or conditions that can cause intellectual disabilities, who died between 2004 and 2008 in England. Epilepsy or unspecified convulsions were involved in 948 deaths (13% of those identifiable) of people with intellectual disabilities or possibly associated conditions. In other people, they were involved in 0.4%. Based on Standardised Mortality Odds Ratios (an approximation of the Standardised Mortality Ratio), adjusting for ages at death, people where death involved epilepsy or unspecified convulsions were 9.7 times more likely than others to have an intellectual disability-related condition (95% CI 9.1, 10.4).
The high prevalence of epilepsy in people with intellectual disabilities, combined with the increased risk of mortality in people with epilepsy, makes the topic of mortality in people with intellectual disabilities and epilepsy a pertinent one. This review aims to summarise studies on mortality in the general population of people with intellectual disabilities and epilepsy and as such it excludes studies on specific syndromes associated with intellectual disabilities. However, the review does include information relating to people with Down syndrome which is by far the most common chromosomal disorder associated with intellectual disability with a prevalence of approximately 1 in 700 live births [17] . Most early studies of mortality in people with intellectual disabilities and epilepsy were hospital based, with an early search of the literature finding no population-based studies including all types of intellectual disabilities on the influence of epilepsy on mortality [18] . Since that time, further studies have been conducted, including population-based studies. In this review, we summarise existing research published from 1990 that quantifies the mortality of people with intellectual disabilities and epilepsy using a comparative statistic relative to either the general population, people with intellectual disabilities who do not have epilepsy, or people with epilepsy who do not have intellectual disabilities. The statistics reported are defined in Table 1 . For all of these, a value of one implies no difference between the two groups, a value of more than one indicates that the risk is greater in the target group, and a value of less than one indicates that the risk is less in the target group. For example, a hazard ratio of two implies double the risk of dying in the target group than in the comparison group. If the hazard ratio is 0.5 then the relative risk of dying in the target group is half the risk of dying in the comparison group. For all of these statistics, the value can be considered statistically significant at p < .05 if the 95% confidence interval does not include one.
Method
Electronic literature database searches were conducted in Medline, Cinahl and PsycINFO on EBSCO. In addition, the reference lists of articles meeting the inclusion criteria were searched and articles from authors' personal collections included. The reference lists of key book chapters were also searched [19] [20] [21] ). Searches were completed on 19 June 2014. Searches included terms relating to both mortality and prevalence to create a pool of articles on mortality or prevalence, with articles on prevalence being retained for a separate review. Searches combined terms for epilepsy, intellectual disabilities, and mortality/prevalence with the Boolean operator 'AND'. Full details of the search terms are given in Appendix One.
Inclusion criteria
Peer reviewed. English language full text. Published from 1990; articles published before this date were excluded as they predate both improvements in epilepsy treatment and major changes in service provision for people with intellectual disabilities [22] . Primary research. Presents a comparative statistic (e.g. relative risk, standardised mortality ratio (SMR), hazard ratio) on mortality in adults or children with intellectual disability and epilepsy compared to the general population, people with intellectual disability without epilepsy, or people with epilepsy without intellectual disability. Samples of adults or children with intellectual disabilities or samples where 50% or more have intellectual disabilities or mixed samples where results are disaggregated for people with intellectual disabilities.
Exclusion criteria
Case studies. Case series. Narrative reviews. Studies based on neonates (new born infants up to 28 days after birth), all other age groups were included. Studies on conditions where intellectual disabilities cannot be assumed (e.g. cerebral palsy, autistic spectrum disorder (ASD)) where results were not disaggregated for people with intellectual disabilities. Studies on specific syndromes associated with intellectual disabilities with the exception of Down syndrome. Less common syndromes were excluded, such as Fragile X syndrome which has a prevalence of 1 in 4000 males and 1 in 8000 females [23] and is not always associated with intellectual disabilities [17] . Does not present a comparative statistic approximating relative risk (e.g. presents only descriptive statistics, presents chisquared analysis).
Initially, titles and abstracts were used to exclude those studies which were obviously not within the scope of reviews on prevalence or mortality. Those retained for further screening were those for which relevance could not be assessed without accessing full text, or those that were chosen as potentially within scope. These studies were screened by the first and second author and discussed until consensus was reached on whether or not they met the inclusion criteria in relation to mortality in people with intellectual disabilities and epilepsy.
Where multiple articles used the same sample or samples were likely to have considerable overlap (e.g. [24, 25] ), only the most recent study was included unless the studies were looking at different topics within the same sample (e.g. [29, 25] are based on The odds (number of times an event happens divided by the number of times it does not happen) of an event occurring in one group divided by the odds of the same event in another group the same sample source but one looks at causes of death, and one looks at whether seizure severity increases mortality). Information from the included studies was extracted by the first author in relation to: authors; year of publication; country of study; study design and study period; sample description; definition of epilepsy; sample size and number of deaths for those with intellectual disabilities and epilepsy; sample size and number of deaths for any comparison group; group that people with intellectual disabilities and epilepsy are compared to; statistic used (e.g. SMR); and main results. This information was tabulated (see Table 2 ). Formal quality assessments were not undertaken as the intention was to include all studies reporting relevant comparative statistics and as such the review does not adhere to PRISMA guidelines [26] . However, elements of studies relevant to quality and risk of bias (i.e. sample representativeness, definition used for ascertainment of epilepsy, sample size) are summarised for each study in Table 2 . Differences in the main characteristics of samples included in the studies and in the definition of epilepsy used were such that it was not possible to conduct meta-analysis to combine estimates of the risk of mortality.
Results
The process of identifying studies for inclusion is summarised in Fig. 1 . Electronic database searches identified a total of 1332 references, with 1099 remaining after removal of duplicates. Following the first examination of studies, 144 remained in a pool of articles relating to mortality or prevalence. After examination of full text articles from this pool and the addition of articles cited within these and from authors' personal collections, 16 articles met the criteria for inclusion in relation to mortality in people with intellectual disabilities and epilepsy.
Country
All studies were from high income countries. There were five studies based on samples from the United States [25, [27] [28] [29] [30] ; four from the United Kingdom (UK) [31, 32, 12, 33] ; three from Finland [34] [35] [36] ; and one from each of the Netherlands [37] , Sweden [18] , Sweden and Denmark [38] , and Japan [39] . The studies are summarised in Table 2 . Figures for 95% confidence intervals are given in parentheses after the point estimate.
Sample representativeness
Few studies were based on samples that could be considered representative of the general population of people with intellectual disabilities and epilepsy. Three studies were based on samples of people with Down syndrome [37, 32, 38] . Two articles using the same data source included those with mild developmental disabilities [25, 29] . One study included those with refractory epilepsy [31] . Other studies were based on samples from specific settings where samples may have been skewed towards those with more severe epilepsy, including those attending one school for those with epilepsy and intellectual disabilities [33] , an institution for those with the most severe disabilities [39] , inpatients and outpatients at one centre for people with intellectual disabilities [34] and patients at three epilepsy centres [30] .
Two studies included comprehensive samples of people with epilepsy including those with and without intellectual disabilities. One study ascertained all children with epilepsy in one US county [28] . Similarly, one study ascertained all children with epilepsy in the catchment area of one hospital [36] . One study used a population-based cohort of people with developmental disabilities but this study did not give exact details for the number of people with intellectual disabilities and epilepsy in the sample, with the result given in Table 2 relating to those with epilepsy and an additional unspecified developmental disability [27] . Three studies included representative samples of people with intellectual disabilities both with and without epilepsy including all those in one province of Finland [18] , those on the Leicestershire Intellectual Disability Register [12] , and a nationwide populationbased sample from Finland [35] .
3.3. All cause mortality in cohorts with intellectual disabilities: comparison of those with or without epilepsy to the general population In a small number of studies, figures are given in relation to all cause mortality for people with intellectual disabilities compared to the general population separately for those with and without epilepsy, or the entire sample including both those with and without epilepsy. For those with mild developmental disabilities (excluding those unable to walk well or with degenerative conditions), the SMR for those with remote symptomatic epilepsy was 4.0 (95% CI 3.6, 4.3) compared to 1.9 (95% CI 1.8, 2.0) for those without epilepsy [25] . For a representative sample of people with intellectual disabilities from Sweden, the SMR was 5.0 (95% CI 3.3, 7.5) for those with intellectual disabilities and epilepsy compared to 2.0 (95% CI 1.7, 2.3) for the entire sample [18] . In this latter study, SMRs are also given in relation to seizure type and frequency: seizure free in the preceding year 2.0 (95% CI 0.9, 4.7); seizures weekly or fewer 4.7 (95% CI 2.8, 7.9); seizures more than weekly 16.8 (95% CI 10.7, 26.5); partial seizures without seizures secondarily generalised 3.7 (95% CI 1.0, 13.6); seizures secondarily generalised 5.0 (95% CI 2.3, 11.0); and seizures generalised from onset 8.1 (95% CI 5.7, 11.5). In a sample from England, the SMRs for people with intellectual disabilities and epilepsy were 3.2 (95% CI 2.7, 3.8) for men and 5.6 (95% CI 4.6, 6.7) for women, whilst the overall SMRs for the entire sample were 2.2 (95% CI 2.0, 2.4) for men and 2.8 (95% CI 2.5, 3.1) for women [12] . Finally, the SMR for overall mortality in a study of pupils at one school for those with severe epilepsy and intellectual disabilities compared to the general population was 15.9 (95% CI 10.6, 23.0) [33] .
All cause mortality in cohorts with intellectual disabilities: comparison of those with and without epilepsy
More commonly, studies compare the mortality of people with intellectual disabilities and epilepsy to people with intellectual disabilities who do not have epilepsy in the same cohort. For people with mild developmental disabilities (excluding those unable to walk well or with degenerative conditions) and remote symptomatic epilepsy, compared to those in the cohort without epilepsy, SMRs were: 1.1 (95% CI 0.8, 1.5) for those who had not had a seizure in the last year; 2.4 (95% CI 1.9, 3.0) for those who had had seizures in the last year but not generalised tonic-clonic (GTC) seizures; 2.9 (95% CI 2.4, 3.4) for those who had had GTC seizures in the last year; and 3.7 (95% CI 2.5, 5.4) for those who had experienced status epilepticus in the last year [29] . In this cohort, those without epilepsy had an SMR of 1.7 (95% CI not stated) compared to the general population. In a later analysis employing the same sample source and exclusions, the overall ratio SMR (the SMR for those with epilepsy divided by the SMR for those without epilepsy) was 2.1 (95% CI 1.9, 2.3) [25] .
In a cohort of inpatients and outpatients of one centre for people with intellectual disabilities, the hazard ratio was 0.87 (95% CI 0.48, 1.61) for inpatients with epilepsy and 1.79 (95% CI 0.76, 4.25) for outpatients with epilepsy [34] . When type of residence was considered for outpatients, the risk of death due to status epilepticus was more than doubled for those in hostels. In a cohort living in one institution for people with severe intellectual [35] . Finally, one study gives a hazard ratio of 2.29 (95% CI 1.50, 3.48) for those with epilepsy compared to those without epilepsy in a cohort of people with Down syndrome aged 45 or more [37] . However, in multivariate survival analysis, age, presence of dementia, and mobility restrictions were the most important predictors of mortality.
All cause mortality in cohorts with epilepsy: comparison of those with or without intellectual disabilities
In other studies, figures are given for cohorts of people with epilepsy depending on whether or not they have an intellectual disability. For those with epilepsy and an additional developmental disability (including but not necessarily intellectual disabilities) the all cause SMR (compared to the general population) was 13.2 (95% CI 7.6, 21.5); for those with epilepsy and no other developmental disability the SMR was 1.5 (95% CI 0.3, 4.3) [27] . In a population-based cohort of children with epilepsy, the hazard ratio for those with intellectual disability compared to those with epilepsy without intellectual disability was 20.86 (95% CI 2.76, 157.97) although only abnormal neurological examination was statistically significant in a multivariate model [28] . Similarly, for those with remote symptomatic epilepsy the hazard ratio for those with severe cognitive impairment was 4.1 (95% CI 2.0, 8.3) [36] . However, only lack of 5-year terminal remission was significant in multivariate analysis.
Causes of death
A small number of studies have considered specific causes of death. One study looked at causes of death in people with mild developmental disabilities (excluding those unable to walk well or with degenerative conditions) and remote symptomatic epilepsy which was noted to be epilepsy occurring in persons with developmental delay or identified brain lesions and excluding idiopathic epilepsy. Ratio SMRs were obtained for those with epilepsy compared to those without epilepsy in the cohort for numerous causes of death including: epilepsy/seizures 53.1 (95% CI 28.0, 101.0); convulsions 25.2 (95% CI 11.7, 54.2); brain cancer 5.2 (95% CI 2.2, 12.1); accidents 2.7 (95% CI 1.9, 3.7); respiratory diseases 1.7 (95% CI 1.2, 2.5) including aspiration pneumonia and accidental inhation 3.0 (95% CI 1.5, 6.0); suicide 1.5 (95% CI 0.3, 6.5); and circulatory diseases 1.3 (95% CI 1.0, 1.7) [25] . Accidental drowning was noted to be the single most significant cause of accidental death. The ratio SMR for accidental drowning, which was included as part of the total accidents figures, was 12.8 (95% CI 7.0, 23.2). The ratio SMR for accidental drowning in those with recent seizures was 15.8 (95% CI 7.2, 34.7). Compared to the general population, the SMR for accidental drowning for those with recent seizures was 35.9 (95% CI not stated) compared to 2.3 (95% CI not stated) for those with no history of epilepsy. The authors note that the excess numbers of deaths due to some causes (e.g. seizures, aspiration, and accidental drowning) must at least in part be attributable to epilepsy. For suicide, the SMR compared to the general population was 0.3 (95% CI not stated) for those with epilepsy and 0.2 for those without epilepsy. Finally, two studies have looked at epilepsy as a cause of death in people with Down syndrome compared to the general population, with one reporting Walczak et a SMR of 17.3 (95% CI 7.4, 34.0) [32] and one reporting a SMR of 30.4 (95% CI 13.9, 57.7) [38] .
3.6.1. SUDEP SUDEP as a cause of death is considered in a small number of studies. In a sample from England, SMRs for SUDEP in people with intellectual disabilities compared to the general population were 37.6 (95% CI 21.9, 60.2) for men and 52.0 (95% CI 23.8, 98.8) for women [12] . A study of pupils at one school for pupils with severe epilepsy and intellectual disabilities found an incidence of SUDEP of 1:295/year [33] . It was noted that all 14 cases of SUDEP occurred when the pupils were not under the close supervision of the school and most were unwitnessed. In a study of those with refractory epilepsy aged under 50, the relative risk of SUDEP was 1.4 (95% CI 0.3, 8.0) for those with a computer recorded history of intellectual disabilities compared to those without [31] . Finally, for patients at three epilepsy centres intellectual disability was a risk factor for SUDEP after adjustment for seizure frequency (odds ratio 4.6 (95% CI 1.2, 18.0)) [30] .
Discussion
People with intellectual disabilities have an elevated risk of death compared to the general population, and the studies reviewed here indicate that this risk is elevated further in those who have co-occurring epilepsy. The risk of death in people with intellectual disabilities and epilepsy has been found to be greater than in the general population by between 3.2 times for men on the Leicestershire Intellectual Disability Register [12] and 16.8 times for those having seizures more than weekly [18] . In comparison, the pooled estimate for mortality in cohorts of people with epilepsy generally has been given as 3.3 (95% CI 2.83, 3.92) [10] . However, there are only four studies which provide a comparative statistic for those with intellectual disabilities and epilepsy compared to the general population [18, 25, 12, 33] .
In a number of studies comparing mortality in people with intellectual disabilities and epilepsy to those with intellectual disabilities without epilepsy in the same cohort, the risk of death has been found to be two or more times greater [39, 25, 37] , although in the latter study only dementia, age at baseline and restricted mobility were significant in multivariate analysis. Further, the risk appears to be associated with seizure type and frequency with those who had not had a seizure in the last year not having an elevated risk of mortality [29] .
For studies involving cohorts of people with epilepsy, increased risk for those with intellectual disabilities has been reported [27, 28] . However, in one of these studies, the risk associated with intellectual disabilities was not significant in multivariate analysis, with abnormal neurological examination being the only significant factor [28] . Similarly, severe cognitive impairment was associated with increased risk in those with remote symptomatic epilepsy but on multivariate analysis only lack of 5 year terminal remission was significant [36] . This suggests that, although mortality in those with intellectual disabilities and epilepsy is significantly elevated, some of this excess is related to underlying conditions, rather than epilepsy per se. As noted in a previous review, the higher mortality in those with intellectual disabilities and epilepsy is partly due to epilepsy being a marker of the severity of disability, and the severity of disability being a predictor of mortality [40] . This issue is considered in the design of one study where it is noted that in the absence of a controlled comparison, it may not be possible to separate the effect of epilepsy on mortality from the effect due to the underlying condition [29] . To address this, Strauss et al. [29] included only those with mild developmental disabilities with minimal motor dysfunction who did not have degenerative conditions. Based on a sample of over 80 thousand, they conclude that epilepsy per se is associated with an increased mortality rate, with the increased mortality risk being evident mainly in those with ongoing seizures.
Causes of death
For people with mild developmental disabilities and remote symptomatic epilepsy, the risk of death related to drowning in those with epilepsy compared to those without epilepsy in the cohort was 12.8 times higher [25] . Compared to the general population, the SMR for drowning was 28.7 for those with remote symptomatic epilepsy, increasing to 35.9 for those with recent seizures. This compared to 2.3 for those with no history of epilepsy.
In the general population of people with epilepsy, the SMR for drowning has been estimated as 18.7 (95% CI 15.0, 23.1) in a metaanalysis of 51 cohorts [11] . These figures suggest that the risk of drowning may be greater for people with mild developmental disabilities and epilepsy than for the general population of people with epilepsy, although this is based on just one study in which the 95% confidence interval around the point estimate is not given.
Over the period 1993 to 2010, SUDEP was the second most common cause of death among adults with epilepsy and intellectual disabilities on the Leicestershire Intellectual Disability Register [12] . Twenty-six people with intellectual disabilities died from probable or definite SUDEP. The SMRs for SUDEP in adults with intellectual disabilities were 37.6 for men and 52.0 for women. The authors acknowledge that this is partly attributable to the higher prevalence of epilepsy among people with intellectual disabilities compared to the general population (the prevalence being 19% in the cohort) but that even taking this into account, people with intellectual disabilities appear to be disproportionately disadvantaged. Similarly, intellectual disability has been found to be a risk factor for SUDEP even after adjusting for seizure frequency [30] . However, for those with refractory epilepsy on the General Practice Research Database (GPRD, a database including over 4 million people registered with a GP in the UK), the relative risk of SUDEP was not significantly increased in people with a history of intellectual disability [31] . The authors acknowledge that with a small number of sudden deaths, confidence intervals are wide and that ascertainment of intellectual disability may not have been complete.
Finally, Day et al. [25] found that in people with developmental disabilities and remote symptomatic epilepsy death rates were elevated for a number of causes including aspiration pneumonia. However, the rate for suicide was lower than that for the general population (although the confidence interval for this estimate is not given). Overall, in relation to cause of death in people with intellectual disabilities and epilepsy, there is a need for more research on cause of death and to facilitate this there is a need for better, detailed recording of death so that cause of death can be determined with some certainty.
Limitations
There are a number of limitations to this review. Whilst studies were identified from a range of countries, the review is restricted to English language publications. Very little information was identified regarding mortality for people with intellectual disabilities and epilepsy in low and middle income (LAMI) countries. However, this is not surprising as there is little information available regarding mortality for people with epilepsy as a whole from LAMI countries. This lack of data has been attributed to the fact that in LAMI countries, incidence studies are difficult, death certificates are not very reliable, autopsies are not easy to obtain, and the cause of death is not usually known with certainty [41] .
The review has included studies relating to mortality in people with intellectual disabilities and epilepsy generally but has only included the most common syndrome associated with intellectual disability (Down syndrome). People with intellectual disabilities are a highly heterogeneous group. Whilst all have a significant general impairment in intellectual functioning that is acquired during childhood, they differ in relation to the cause and severity of the intellectual disability which may result from a complex interaction between biomedical, social, behavioural and educational factors [17] . Further, life expectancy can vary markedly between specific syndromes associated with intellectual disabilities. For example, mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is associated with early death, generally during the second or third decade of life [42] , whilst life expectancy in fragile X syndrome is not greatly reduced [43] . Future reviews could consider the issue of mortality in other syndromes that are associated with intellectual disabilities. It is evident that research related to epilepsy in such syndromes, although not necessarily in relation to mortality, does exist (e.g. [44] ).
All data were extracted by one reviewer and extraction of data by two reviewers independently would have reduced the possibility of errors. Ideally, the same definition of epilepsy should be used across studies to allow comparison of mortality rates. However, the studies identified use a variety of definitions of epilepsy as shown in Table 2 . Further, for some studies the confidence intervals around point estimates are extremely wide.
Finally, many of the studies include cohorts for time periods that preceded the development of more recent anti-epileptic drugs (AEDs). It has been noted that after a 15 year period with no new treatments, five drugs for epilepsy were approved from 1993 to 1997 [45] . As such, the relevance of early cohorts to current practice may be restricted. As poor seizure control appears to be a risk factor for mortality, future studies may show a diminished risk of mortality due to wider variety of treatment options.
Conclusion
The evidence base identified for this review is small and further research is needed to substantiate some of the findings reported here. However, the evidence suggests that people with intellectual disabilities and epilepsy do have a substantially increased risk of mortality, particularly where seizures are ongoing. It is important that services are equipped with the information and skills needed to manage epilepsy in this population. A recent report provides information on reasonable adjustments that can be made to improve epilepsy care for people with intellectual disabilities [46] . The ideas, information and examples of good practice in relation to reasonable adjustments provided within this report should help services improve provision for this highly prevalent condition and potentially reduce the excess deaths associated with epilepsy in people with intellectual disabilities.
